Chronic Asthma (Stable/Between-Attack)

Populations and Risk Factors

• Affects approximately 8.2% of adults and 9.4% of children in the United States; most frequent cause of childhood hospitalization
• Higher prevalence in Black and Hispanic children and those in urban or lower-income areas; adult-onset asthma is more common in women
• Atopic triad: individuals with asthma frequently also have allergic rhinitis and eczema — the presence of one atopic condition increases risk for the others
• Occupational asthma from prolonged exposure to irritants (flour dust, chemical fumes, animal proteins) accounts for approximately 15% of adult-onset cases
• Obesity is an independent risk factor — increases both incidence and severity, partly through mechanical restriction of diaphragmatic excursion and systemic inflammatory mediators
• Comorbidities: GERD (reflux-triggered bronchospasm), aspirin/NSAID sensitivity (aspirin-exacerbated respiratory disease with nasal polyps), anxiety disorders (bidirectional relationship — anxiety worsens asthma control, poorly controlled asthma increases anxiety)
• Hygiene hypothesis: reduced childhood exposure to diverse microbial environments may bias immune development toward TH2-dominant allergic responses
• Family history of asthma or atopy increases risk 3–6 times

Causes and Pathophysiology

Airway Inflammation — The Persistent Driver

• Chronic asthma is fundamentally an inflammatory disease, not simply a bronchoconstriction disease. Even between attacks, the airway mucosa maintains a low-grade inflammatory infiltrate dominated by eosinophils, TH2 lymphocytes, and mast cells. This persistent inflammation is why patients have symptoms and structural changes even when they feel "fine."
• IgE-mediated sensitization: on allergen exposure, mast cells bound with allergen-specific IgE degranulate, releasing histamine, prostaglandins, and leukotrienes. Histamine causes immediate bronchospasm (minutes); leukotrienes sustain inflammation for hours. This two-phase response explains why a patient may wheeze briefly, improve, then worsen again 4–8 hours later (late-phase reaction).
• Nocturnal pattern: asthma symptoms are characteristically worst around 4:00 AM, coinciding with the circadian nadir of endogenous cortisol and peak eosinophil activity. This matters clinically because early-morning appointments may coincide with peak symptom periods.

Airway Remodeling — Why "Between Attacks" Is Not "Normal"

• Chronic unmanaged inflammation drives structural remodeling: smooth muscle hypertrophy and hyperplasia thicken the bronchial wall, subepithelial fibrosis deposits collagen beneath the basement membrane, and goblet cell hyperplasia increases mucus production. These changes are partially irreversible and explain why long-standing asthma behaves increasingly like COPD over time.
• Airway remodeling reduces the baseline caliber of the airways permanently, so that less additional bronchoconstriction is needed to produce obstruction. A patient with significant remodeling can become symptomatic from triggers that would not affect someone with early-stage asthma.

Chronic Hyperinflation — The Mechanical Consequence

• During bronchospasm, air enters the lungs on inhalation (airways open during negative intrathoracic pressure) but cannot fully exit on exhalation (narrowed airways collapse under positive pressure). This air trapping increases functional residual capacity — the lungs remain partially overinflated even at rest.
• Chronic hyperinflation flattens the diaphragm by pushing it inferiorly. A flattened diaphragm loses its dome-shaped mechanical advantage: instead of descending efficiently to create negative thoracic pressure, it contracts horizontally with minimal downward excursion. This single mechanical change forces the recruitment of accessory muscles for routine breathing — even between attacks.
• The thoracic cage adapts to the chronically overinflated position: the ribs elevate and externally rotate, the A-P diameter increases (barrel chest in severe cases), and costovertebral joint mobility decreases. Thoracic kyphosis increases as the upper thoracic spine rounds forward to accommodate the fixed rib position.

Accessory Muscle Recruitment — Why the MSK Findings Exist

• With diaphragm efficiency reduced, the scalenes, sternocleidomastoid (SCM), pectoralis minor, upper trapezius, serratus posterior superior, and levator scapulae are chronically recruited to elevate the rib cage during inspiration. These muscles are designed as emergency breathing muscles — short-burst, high-force — not for sustained tidal breathing. Chronic recruitment produces hypertonicity, trigger points, fascial shortening, and eventually fibrotic tissue changes.
• Pectoralis minor shortening from chronic recruitment pulls the scapula into anterior tilt and protraction, contributing to an upper crossed syndrome pattern: tight pectorals and upper trapezius with inhibited deep neck flexors and lower trapezius/serratus anterior. This postural adaptation is not a separate pathology — it is a direct mechanical consequence of the breathing dysfunction.
• The intercostals (both internal and external) are chronically loaded. External intercostals assist with forced inspiration; internal intercostals assist with forced expiration (which is active in asthma rather than passive). Both groups develop hypertonicity and reduced extensibility, contributing to decreased rib excursion independent of airway obstruction.
• Diaphragm shortening: the chronically flattened diaphragm adapts by shortening its muscle fibers, further reducing its contractile range. This creates a self-perpetuating cycle — reduced diaphragm function increases accessory muscle demand, which increases upper chest breathing dominance, which further reduces diaphragmatic engagement.

Breathing Pattern Dysfunction

• The combined effect of diaphragm inefficiency, accessory muscle recruitment, and reduced thoracic compliance produces a characteristic breathing pattern: shallow, rapid, upper-chest-dominant breathing with minimal abdominal excursion. This pattern persists even when airways are not acutely obstructed.
• Chronic upper chest breathing pattern maintains the accessory muscles in their shortened, hypertonic state and perpetuates the thoracic postural changes. It also contributes to a chronic state of mild respiratory alkalosis from over-ventilation, which can amplify anxiety and the sensation of breathlessness — creating a feedback loop between breathing dysfunction and psychological distress.

Anxiety and Muscle Guarding

• Asthma creates a conditioned fear response: repeated episodes of air hunger produce anticipatory anxiety even when airways are currently open. This anxiety manifests as muscle guarding in the chest wall, jaw (masseters and temporalis), upper trapezius, and suboccipital region.
• The guarding pattern is distinct from the accessory breathing muscle hypertonicity: it is driven by sympathetic nervous system activation and central sensitization rather than mechanical demand. Both patterns coexist in the chronic asthma patient and require different treatment approaches — the breathing muscles need mechanical release and retraining, while the anxiety-driven guarding responds to parasympathetic activation and relaxation techniques.
• Sympathetic dominance from chronic anxiety also increases baseline bronchomotor tone, making the airways more reactive to triggers. Parasympathetic activation during relaxation-focused MT has the potential to reduce this baseline reactivity — one of the physiological rationales for treating chronic asthma patients.

Medication Effects — What the MT Must Know

• Inhaled corticosteroids (ICS) (fluticasone, budesonide): first-line maintenance therapy; reduce airway inflammation. Local side effects include oral candidiasis (thrush) and hoarseness/dysphonia from laryngeal myopathy. The client may have throat discomfort or voice changes that are medication-related, not pathological.
• Short-acting beta-agonists (SABA) (salbutamol/albuterol): rescue inhaler for acute bronchospasm. Side effects include skeletal muscle tremor (particularly hands), tachycardia, and anxiety/nervousness. An MT may notice hand tremor during the session — this is a medication effect, not a neurological finding.
• Long-acting beta-agonists (LABA) (salmeterol, formoterol): maintenance bronchodilation; same side effects as SABA but sustained. Always used in combination with ICS, never alone.
• Oral corticosteroids (prednisone): used in severe or poorly controlled asthma. Systemic effects relevant to MT include: skin fragility and easy bruising (reduced collagen synthesis), proximal myopathy (especially quadriceps and hip girdle), osteoporosis with increased fracture risk, adipose redistribution (truncal obesity, moon face), and impaired wound healing. Pressure must be reduced for patients on chronic oral corticosteroids.
• Leukotriene receptor antagonists (montelukast): oral maintenance therapy; generally well tolerated. Rare but notable: mood changes, including anxiety and depression.
• Nutrient depletion note: Long-term inhaled corticosteroid use has low-level systemic absorption that can deplete calcium and vitamin D over years, contributing to osteoporosis risk in chronic asthma patients — especially those who also receive intermittent oral corticosteroid bursts during exacerbations. Clients with long-standing asthma on high-dose ICS plus occasional oral prednisone may have cumulative bone density loss exceeding what either route alone would produce. See pharmacology-for-massage-therapists/drug-nutrient-depletion-reference.

Signs and Symptoms

Stable/Well-Controlled Asthma

• Symptoms occur fewer than twice per week; nighttime awakening fewer than twice per month
• Normal or near-normal lung function (FEV1 > 80% predicted)
• No limitation in daily activities
• Rescue inhaler use fewer than twice per week
• MSK findings may still be present: mild accessory muscle hypertonicity, mildly reduced thoracic mobility, upper chest breathing pattern that the patient considers normal
• Barrel chest is typically absent or mild; posture may show early upper crossed pattern

Partially Controlled / Poorly Controlled Asthma

• Daytime symptoms more than twice per week; any nighttime awakening
• Activity limitation from breathlessness
• Rescue inhaler needed more than twice per week
• Pronounced accessory muscle hypertonicity and tenderness — scalenes, SCM, upper trapezius, pectoralis minor are visibly or palpably tense even at rest
• Barrel chest development with increased A-P thoracic diameter
• Visible upper chest breathing pattern: shoulders elevate with each breath, minimal abdominal movement
• Exercise-induced bronchospasm (EIB): wheezing, cough, or chest tightness during or shortly after exertion, which may be the only trigger in some patients
• Chronic dry cough, especially nocturnal or early morning

Severe/Refractory Asthma

• Daily symptoms despite maximal medication; frequent nighttime awakening
• Significant activity limitation; frequent exacerbations requiring oral corticosteroids or emergency care
• FEV1 < 60% predicted even on maximum therapy
• Prominent barrel chest and chronic hyperinflation
• Marked upper crossed pattern: forward head, rounded shoulders, thoracic hyperkyphosis
• Skin fragility and muscle wasting from chronic oral corticosteroid use
• Significant anxiety component; may have comorbid panic disorder
• Silent asthma variant: no warning symptoms before sudden life-threatening dyspnea — particularly dangerous because neither patient nor therapist gets an early signal

Assessment Profile

Subjective Presentation

• Chief complaint: "My shoulders and neck are always tight," "I carry all my tension in my chest and upper back," or "I can never take a full, deep breath." Many chronic asthma patients present with MSK complaints rather than respiratory complaints — they have adapted to their breathing pattern and consider it normal. Always ask about asthma history when a client presents with chronic upper trapezius/scalene/pectoral tightness.
• Pain quality: deep muscular aching and stiffness in the upper trapezius, scalenes, and pectoral region; intercostal soreness described as "bruised ribs" or "sore when I breathe deeply"; may report jaw clenching or temporal headache from masseter and temporalis tension (anxiety-driven guarding); thoracic stiffness described as "can't straighten up" or "always slouching"
• Onset: insidious development of MSK symptoms over months to years, parallel to asthma duration and control level; patients often cannot identify a specific onset because the changes accumulated gradually; symptoms worsen during periods of poor asthma control, allergy seasons, or high stress
• Aggravating factors: cold air exposure, respiratory infections, allergy season, exercise without adequate warm-up, strong scents or airborne irritants, emotional stress, prolonged static postures (desk work compounds the upper crossed pattern), prone lying (compresses the chest and increases work of breathing)
• Easing factors: rescue inhaler use relieves acute bronchospasm but not the MSK component; warm showers or heat to the upper back and shoulders relieve muscle tension temporarily; sitting upright or leaning forward (tripod position) eases breathing effort; relaxation techniques and slow breathing exercises reduce both the breathing dysfunction and the anxiety-driven guarding
• Red flags: sudden onset of wheezing, chest tightness, or severe dyspnea during treatment indicates an acute asthma attack — stop treatment, sit the client up, assist with rescue inhaler, call emergency services if no improvement within 5–10 minutes; do not resume treatment. Persistent worsening of baseline symptoms despite regular medication → medical referral for reassessment of asthma control level. New hemoptysis (coughing blood) → urgent medical referral.

Observation

• Local inspection: accessory breathing muscles may be visibly hypertrophied (scalenes, SCM) in moderate to severe asthma; intercostal retractions visible during deeper breathing efforts; increased A-P thoracic diameter (barrel chest) in poorly controlled or long-standing disease; no swelling, bruising, or skin changes unless on chronic oral corticosteroids (in which case skin may appear thin, easily bruised, with striae)
• Posture: upper crossed syndrome pattern — forward head posture, protracted and anteriorly tilted scapulae (pectoralis minor shortening), increased thoracic kyphosis, elevated shoulders (upper trapezius and levator scapulae hypertonicity); observe breathing pattern at rest — count respiratory rate (normal 12–20/min; chronic asthma patients often 16–22/min) and note whether breathing is primarily upper chest (clavicular rise, shoulder elevation) or includes visible abdominal excursion
• Gait: typically normal unless asthma is severe with significant activity limitation; may show reduced arm swing from pectoral and shoulder girdle tightness; in severe cases with marked kyphosis, a forward-flexed trunk posture during ambulation

Palpation

• Tone: bilateral hypertonicity of the accessory breathing muscles — scalenes (anterior, middle, and posterior), SCM, upper trapezius, levator scapulae, pectoralis minor, and pectoralis major (clavicular head); intercostals (both internal and external) palpate as taut bands with reduced extensibility between ribs; suboccipital muscles hypertonic from forward head posture; masseter and temporalis tension from anxiety-driven jaw clenching; the pattern is characteristically bilateral and symmetric (unlike cervical radiculopathy or thoracic outlet syndrome which tend to present unilaterally or asymmetrically); chronic fibrotic changes in long-standing cases versus acute protective guarding in recently decompensated patients
• Tenderness: lateral cervical region (scalene triangle) — tender on palpation with referral into the upper extremity if trigger points are active (scalene TrPs can mimic thoracic outlet symptoms); intercostal spaces, particularly anterolateral ribs 3–6, tender to direct palpation from chronic overload; pectoralis minor insertion at the coracoid process; upper trapezius at the angle of the neck; SCM along its full length; costovertebral joints at the thoracic spine (T1–T8) may be tender from restricted articulation; diaphragm attachment along the inferior costal margin (ribs 7–12) — tenderness here reflects diaphragm shortening and chronic strain at the musculotendinous junction
• Temperature: typically normal; no acute inflammatory process at the MSK level; warmth would suggest a concurrent inflammatory condition rather than asthma-related MSK changes; skin temperature may be cool in anxious patients due to peripheral vasoconstriction from sympathetic dominance
• Tissue quality: accessory breathing muscles have a ropy, taut quality from chronic overuse — particularly the scalenes and SCM; pectoralis minor may feel fibrotic and shortened, pulling the coracoid process anteriorly when palpated in the axillary fold; intercostal tissue feels inelastic with reduced compliance on rib spring testing; trigger points common in scalenes (referral to upper extremity and chest), upper trapezius (referral to temporal region), SCM (referral to forehead, ear, and orbit), and pectoralis minor (referral to anterior chest and medial arm); thoracic paraspinal muscles (erector spinae group) may be elongated but hypertonic from chronic kyphotic posture — they are working constantly against gravity to resist further kyphosis

Motion Assessment

• AROM: thoracic rotation and lateral flexion reduced bilaterally — the stiffened rib cage limits segmental thoracic mobility; cervical extension may be limited by suboccipital and scalene shortening; shoulder flexion and abduction may be restricted at end-range by pectoralis minor shortening (scapular anterior tilt prevents full scapular upward rotation); deep inspiration ROM (maximum chest expansion measured at the nipple line or fourth intercostal space) reduced — normal is > 5 cm difference between full expiration and full inspiration; chronic asthma patients typically measure 2–4 cm; range does not significantly improve with warm-up (unlike DDD), because the restriction is structural (rib cage compliance) and muscular (intercostal and accessory muscle shortening)
• PROM / end-feel: costovertebral joint springing (posteroanterior pressure on ribs) meets a firm, early end-feel from capsular restriction and muscular guarding; cervical lateral flexion PROM may exceed AROM slightly (protective guarding component reduces with slow sustained stretch); thoracic rotation end-feel is firm/leathery from intercostal and paraspinal shortening; pectoral stretch (passive horizontal abduction) meets a muscular end-feel with early limitation from pectoralis minor fibrotic shortening
• Resisted testing: generally normal strength throughout; may find weakness in the lower trapezius and serratus anterior (inhibited in upper crossed pattern — not from nerve damage but from reciprocal inhibition by the chronically tight antagonists); resisted shoulder flexion and abduction are typically pain-free but may reproduce pectoral discomfort at end-range if the pectoralis minor is significantly shortened

Special Test Cluster

Inhaler availability check: Before beginning treatment, confirm the client has their rescue inhaler within reach on the treatment table or nearby surface. This is not a diagnostic test — it is a safety protocol. If the client does not have their inhaler, do not proceed until one is available. Also ask: "When did you last use your rescue inhaler?" and "How would you describe your asthma control this week?" If the client reports using their rescue inhaler more than twice in the past week or describes worsening symptoms, adjust treatment conservatively (lighter work, avoid prone, shorter session).

Differential Assessment